Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Church & Dwight (CHD) Beats On Q1 Earnings & Revenues

Published 05/05/2016, 10:51 PM
Updated 07/09/2023, 06:31 AM

Driven by robust organic sales and gross margin expansion, Church & Dwight Co. Inc. (NYSE:CHD) , reported first-quarter 2016 earnings per share of 86 cents, which increased 7.5% year over year and also surpassed the Zacks Consensus Estimate by a couple of cents.

The top line climbed 4.5% to $849 million and surpassed the Zacks Consensus Estimate of $828 million. Organic sales grew 5.2% on the back of 5.6% increase in volumes. However, unfavorable product mix and pricing partially limited the upside.

Gross profit inched up 6.6% year over year to $379 million. Gross margin expanded 80 basis points (bps) to 44.6% driven by lower commodities, productivity programs as well as the effect of higher margin businesses.

Selling, general, and administrative (SG&A) expenses increased 12.6% to $107 million during the quarter due to incremental amortization from acquisitions as well as a rise in incentive compensation.

On the other hand, operating income rose 4.3% year over year to $179.5 million in the quarter, while operating margin contracted approximately 10 bps to 21.1%.

Segment Details

Net sales for Consumer Domestic improved 5.4% year over year to $647.8 million. Organic sales also edged up 4.5% in the quarter due to increase in sales of liquid laundry detergent, BATISTE dry shampoo, VITAFUSION gummy vitamins, and the ARM & HAMMER CLUMP & SEAL.

Sales at the Consumer International segment increased 5.8% to $127.4 million. Organic sales grew 13.3%, mainly on the back of healthy sales in Europe, Canada and Mexico. Volumes jumped 9.6%. Favorable product mix and pricing contributed 3.7% to sales.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Specialty Products witnessed a 4.6% decrease in sales to $73.8 million. Moreover, the segment recorded a 2% fall in organic sales as well as a 1.4% decline in volume, primarily due to lower milk pricing.

Other Financial Details

Church & Dwight, which shares space with The Procter & Gamble Company (NYSE:PG) and The Clorox Company (NYSE:CLX) , ended the year with cash and cash equivalents of $194.3 million, long-term debt of $699.8 million and shareholders’ equity of $1,920.3 million.

Moreover, the company generated cash from operations of $177.8 million and incurred nearly $8.5 million in capital expenditures in the first three months of 2016.

Outlook

Church & Dwight remains optimistic about its future performance on the back of a stable portfolio of value and premium products, the launch of new and innovative products, aggressive productivity programs and tight management of overhead expenses. Management also remains confident about achieving the 2016 targets despite the stiff competition anticipated in the year.

Church & Dwight expects adjusted earnings in 2016 to grow by roughly 7–9% backed by the ongoing growth momentum, product innovations and increase in gross margin. The company expects reported earnings per share to grow in the range of 13–15%.

Also, the company now expects organic sales growth of 3–4% in 2016 as against 3% growth projected earlier. The company anticipates gross margin expansion of 75 bps year over year. Also, operating margin is estimated to improve nearly 50 bps.

For the second quarter of 2016, the company expects organic sales growth of 2–3%. Earnings per share are envisioned to be $0.79.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

At present, Church & Dwight has a Zacks Rank #2 (Buy). Another favourably placed stock in this sector is Unilever PLC (NYSE:UL) , which holds the same Zacks rank as Church & Dwight.



UNILEVER PLC (UL): Free Stock Analysis Report

PROCTER & GAMBL (PG): Free Stock Analysis Report

CHURCH & DWIGHT (CHD): Free Stock Analysis Report

CLOROX CO (CLX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.